Wenkel Martin, Halloum Nancy, Neufang Achim, Doemland Marco, Pfeiffer Philipp, Ghazy Ahmad, Probst Chris, Dohle Daniel-Sebastian, Treede Hendrik, El Beyrouti Hazem
Department of Cardiac and Vascular Surgery, University Medical Centre Mainz, Johannes Gutenberg University, 55131 Mainz, Germany.
J Cardiovasc Dev Dis. 2025 Mar 14;12(3):99. doi: 10.3390/jcdd12030099.
BACKGROUND/OBJECTIVES: The frozen elephant trunk (FET) technique was introduced as a possible single-stage procedure for treating aortic arch pathologies. However, up to a third of patients are reported to need subsequent completion (extension). This retrospective analysis aimed to evaluate the impact of early (within 30 days; EC group) versus late (>30 days; LC group) endovascular completion with thoracic endovascular aortic repair (TEVAR) in patients treated with FET.
A single-center, retrospective analysis of all consecutive patients for the period between June 2017 and December 2023 who underwent FET and received endovascular extension was conducted. Indications for endovascular extension were aneurysms of the descending aorta, aneurysmal progress, endoleak, malperfusion, distal stent-induced new entry (dSINE), and aortic rupture.
A total of 37 of 232 FET patients received endovascular extension (15.9%). Average age at the time of TEVAR was 63.3 ± 10.3 years. There was an increase in the maximum total aortic diameter post-FET from 40.8 ± 9 mm to 45.1 ± 14 mm prior to TEVAR. Only 14 patients (37.8%) had the desired complete occlusion of the false lumen or aneurysm prior to extension; 23 (62.2%) still had relevant perfusion of the false lumen or aneurysm. The EC and LC groups were defined by time between FET and TEVAR: a mean of 4.8 ± 5.2 days in the EC group and 18.4 ± 18 months in the LC group. The EC group had markedly more complex procedures, reflected in intensive care (10.7 ± 6.9 vs. 0.1 ± 0.3 days, < 0.001) and hospitalization (22.4 ± 14.0 vs. 8.1 ± 5.6 days, = 0.003) durations. There was one early death due to multiorgan failure in the EC group and there were none in the LC group. There were no major cardiac events in either group. In the EC group, seven patients (50%) suffered from postoperative respiratory failure and four (28.6%) developed acute kidney failure requiring dialysis. Only one patient in the LC group (4.3%) experienced complications. During follow-up, another three patients (21.4%) of the EC group died, but none of the LC group did. Post-extension aortic remodeling was similar in both groups, with complete occlusion achieved in 27 cases (72%) during early follow-up and increased to 90.6% after a mean of 22.0 ± 23.4 months.
Following aortic arch repair using FET, there is still a need for second-stage repair in 16% of patients. Endovascular completion post-FET is safe and feasible with a technical success rate of 100%, but early completion is associated with greater morbidity and mortality. TEVAR extension surgery may be better delayed, if possible, until after recovery from the hybrid arch repair.
背景/目的:冷冻象鼻(FET)技术作为一种治疗主动脉弓病变的可能的单阶段手术被引入。然而,据报道高达三分之一的患者需要后续的完成手术(延长手术)。这项回顾性分析旨在评估在接受FET治疗的患者中,早期(30天内;EC组)与晚期(>30天;LC组)通过胸主动脉腔内修复术(TEVAR)进行血管腔内完成手术的影响。
对2017年6月至2023年12月期间所有连续接受FET并接受血管腔内延长手术的患者进行单中心回顾性分析。血管腔内延长手术的指征包括降主动脉瘤、动脉瘤进展、内漏、灌注不良、远端支架诱导的新破口(dSINE)和主动脉破裂。
232例FET患者中有37例接受了血管腔内延长手术(15.9%)。TEVAR时的平均年龄为63.3±10.3岁。FET后至TEVAR前,主动脉最大总直径从40.8±9mm增加到45.1±14mm。在延长手术前,只有14例患者(37.8%)实现了假腔或动脉瘤所需的完全闭塞;23例(62.2%)仍有假腔或动脉瘤的相关灌注。EC组和LC组根据FET与TEVAR之间的时间定义:EC组平均为4.8±5.2天,LC组为18.4±18个月。EC组的手术明显更复杂,这反映在重症监护时间(10.7±6.9天对0.1±0.3天,<0.001)和住院时间(22.4±14.0天对8.1±5.6天,=0.003)上。EC组有1例因多器官衰竭早期死亡,LC组无死亡病例。两组均无重大心脏事件。在EC组,7例患者(50%)术后发生呼吸衰竭,4例(28.6%)发生急性肾衰竭需要透析。LC组只有1例患者(4.3%)出现并发症。在随访期间,EC组又有3例患者(21.4%)死亡,而LC组无死亡病例。两组术后主动脉重塑相似,早期随访期间27例(72%)实现了完全闭塞,平均22.0±23.4个月后增加到90.6%。
在使用FET进行主动脉弓修复后,仍有16%的患者需要二期修复。FET后的血管腔内完成手术是安全可行的,技术成功率为100%,但早期完成手术与更高的发病率和死亡率相关。如果可能,TEVAR延长手术可能最好推迟到杂交弓修复术后恢复。